Chemoinformaics analysis of Javanicinosides C
| Molecular Weight | 538.59 | nRot | 5 |
| Heavy Atom Molecular Weight | 500.286 | nRig | 28 |
| Exact Molecular Weight | 538.241 | nRing | 5 |
| Solubility: LogS | -2.391 | nHRing | 2 |
| Solubility: LogP | -0.051 | No. of Aliphatic Rings | 5 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
| Atoms Count | 76 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 38 | No. of Aromatic Carbocycles | 0 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 38 | No. of Saturated Hetero Cycles | 2 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 3 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 0 |
| nHA | 11 | APOL | 79.2501 |
| nHD | 4 | BPOL | 48.5379 |
| QED | 0.344 |
| Synth | 5.649 |
| Natural Product Likeliness | 2.657 |
| NR-PPAR-gamma | 0.135 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.925 |
| Pgp-sub | 0.996 |
| HIA | 0.511 |
| CACO-2 | -5.254 |
| MDCK | 0.000140554 |
| BBB | 0.106 |
| PPB | 0.269453 |
| VDSS | 1.173 |
| FU | 0.519469 |
| CYP1A2-inh | 0.001 |
| CYP1A2-sub | 0.558 |
| CYP2c19-inh | 0.007 |
| CYP2c19-sub | 0.666 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.036 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.107 |
| CYP3a4-inh | 0.063 |
| CYP3a4-sub | 0.371 |
| CL | 2.858 |
| T12 | 0.147 |
| hERG | 0.003 |
| Ames | 0.898 |
| ROA | 0.224 |
| SkinSen | 0.027 |
| Carcinogencity | 0.033 |
| EI | 0.005 |
| Respiratory | 0.955 |
| NR-Aromatase | 0.361 |
| Antiviral | Yes |
| Prediction | 0.761277 |